Embed Size (px)
Citation preview
Extraordinary Strategic Advisory Group of Experts on Immunization (SAGE) meeting
on Influenza A(H1N1) vaccines 7 July 2009
CCV/CICG, Geneva
Final list of participants
SAGE members Professor Jon S. Abramson (Member of H1N1 Working Group) Wake Forest University 1834 Wake Forest Road Winston-Salem 27106 NC United States of America
tel: 1 336 716 2512 fax: 1 336 716 9699 e-mail: [email protected]
Professor Hyam N. Bashour (Unable to attend) Professor of Epidemiology and Community Health, Deputy Dean for Scientific Affairs Department of Family and Community Medicine University of Damascus Faculty of Medicine P.O. Box 9241 Damascus Syr ia
tel: +963 11 2117403; +963 11 661832 fax: +963 11 2117404 e-mail: [email protected]; [email protected]
Professor Zulfiqar Ahmed Bhutta (Unable to attend) Head Maternal and Child Health Division The Aga Khan University P.O. Box 3500 Stadium Road Karachi 74800 Pakistan
tel: +92 21 493 9202 fax: +92 21 493 4294 e-mail: [email protected]
Dr Supamit Chunsuttiwat (Member of H1N1 Working Group) Senior Medical Officer Department of Disease Control Ministry of Public Health Tiwanon Road 11000 Nonthaburi Thai land
tel: +662 590 3370 fax: +662 591 8432 e-mail: [email protected]
Professor David Durrheim (Linked by telephone) Director of Health Protection, Hunter New England Area Health Service and Professor of Public Health Newcastle University Locked Bag 10 Wallsend 2287 NSW Austra l ia
tel: +61-2-492 46395 fax: +61 2 492 46048 e-mail: [email protected]
Dr J. Peter Figueroa (Linked by telephone) Professor, Public Health, Epidemiology & AIDS, Department of Community Health & Psychiatry Faculty of Medical Sciences University of the West Indies Mona Kingston 7 Jamaica
tel: +1 876-970-3252 fax: +1 876 967 1643 e-mail: [email protected]
Version: 29.07.2009 2
Dr Xiaofeng Liang Director of National Immunization Programme China Center for Disease Control and Prevention - Ministry of Health China Center for Disease Control and Prevention 27 Nanwei Lu Beijing 100050 People 's Republ ic of China
tel: +86 10 631 76 737 fax: + 86 10 631 71 724 e-mail: [email protected]
Professor Elizabeth Miller (Unable to attend) Head Immunisation Department Health Protection Agency Centre for Infections 61 Colindale Avenue London NW9 5EQ United Kingdom of Great Br i ta in & Northern I re land
tel: 44 208 327 7430 (direct) fax: 44 208 327 7404 e-mail: [email protected]
Professor Helen Rees Professor Obstetrics & Gynaecology Reproductive Health and HIV Research Unit University of the Witwatersrand PO Box 18512 Hillbrow 2038 Johannesburg South Afr ica
tel: +27 11 358 5402 fax: +27 11 358 5301 e-mail: [email protected]; [email protected];
Professor Arthur Lawrence Reingold Head, Division of Epidemiology School of Public Health University of California, Berkeley 140 Warren Hall Berkeley 94720-7360 CA United States of America
tel: +1 510 642 0327 fax: +1 510 643 5163 e-mail: [email protected]; [email protected]
Professor David Salisbury (Chair of SAGE and H1N1 Working Group) Director of Immunisation Department of Health Wellington House 510, Wellington House 133-155 Waterloo Road London SE1 8UG United Kingdom of Great Br i ta in & Northern I re land
tel: +44 207 972 4377 fax: +44 207 972 3989 e-mail: [email protected]
Dr Jane Soepardi Head of Sub-Directorate of Immunization Ministry of Health and Sanitation Jalan Percetakan Negara 20 P.O. Box 223 Jakarta 10560 Indonesia
tel: +62 21 754 4158 fax: +62 21 428 04 154 e-mail: [email protected] ;
Dr Oyewale Tomori Professor of Virology Redeemer's University Km 46 Lagos-Ibadan Express Road P.O. box 7914, IKEJA Lagos State Niger ia
tel: +234 1 793 1780 fax: e-mail: [email protected]; [email protected]
Version: 29.07.2009 3
H1N1 Working Group members
Dr Nancy J. Cox Director, of Influenza Division, National Center for Immunization & Respiratory Diseases Centers for Disease Control and Prevention National Center for Infectious Diseases 1600 Clifton Rd. NE Atlanta, GA 30333 United States of America
tel: +1404 639 3591 fax: +1 404 639 2334 e-mail: [email protected]
Professor Neil Ferguson (Linked by telephone) Professor of Mathematical Biology MRC Centre for Outbreak Analysis and Modelling Imperial College St. Mary's Campus Norfolk PLace Paddington London W2 1PG United Kingdom of Great Br i ta in & Northern I re land
tel: +44 207 594 3296 fax: +44 207 262 3495 e-mail: [email protected]
Mrs Teeranart Jivapaisarnpong Director, Division of Biological Products Department of Medical Sciences Ministry of Public Health Nonthaburi 11000 Thai land
tel: +662 965 9723 fax: +662 5915448 e-mail: [email protected]; [email protected]
Professor Paul-Henri Lambert Center for Vaccinology Centre Médical Universitaire 1 rue Michel Servet 4 Genève 1211 Switzer land
tel: +41 22 379 5783 fax: +41 22 702 5801 e-mail: [email protected]
Professor Joahnnes Lower President Paul-Ehrlich-Institut Paul Ehrlich Strasse 51-59 Postfach 1740 Langen 63225 Germany
tel: 496103771000 fax: 496103771240 e-mail: [email protected]
Dr Karen Midthun Deputy Director for Medicine Center for Biologics Evaluation and Research 1401 Rockville Pike 200N (HFM-6) Rockville MD 20892 United States of America
tel: +1 301 827 0372 fax: +1 301 827 0440 e-mail: [email protected]
Dr Philip Minor Head, Division of Virology (Chair ECBS) National Institute for Biological Standards and Control Blanche Lane, South Mimms Potters Bar Herts EN6 3QG United Kingdom of Great Br i ta in & Northern I re land
tel: +44 1707 641 312 fax: +44 1707 641 050 e-mail: [email protected]
Version: 29.07.2009 4
Professor Albert Osterhaus Head of the Department of Virology Erasmus MC, Dr Molewaterplein 50 P.O. Box 2040 Rotterdam 3000 CA Nether lands
tel: +31 10 704 4066 fax: 31 10 408 9485 e-mail: [email protected]
Dr Stefania Salmaso (Linked by telephone) Director Centro Nazionale di Epidemiologia CNESPS Istituto Superiore di Sanità Viale Regina Elena, 299 00161 Rome I ta ly
tel: +39 06 4990 4010 (4012-4013) fax: +39 06 49904111 e-mail: [email protected]
Professor Peter Smith (Chair GACVS) Department of Epidemiology and Population Health London School of Hygiene and Tropical Medicine Keppel Street London WC1E 7HT United Kingdom of Great Br i ta in & Northern I re land
tel: +44 207 927 2246 fax: +44 207 927 2666 e-mail: [email protected]
TCG/TAG Chairs
Dr Ciro de Quadros Executive Vice-President (AMRO TAG Chair) Sabin Vaccine Institute 2000 Pennsylvania Avenue NW Suite 7100 Washington 20006 DC United States of America
tel: +1 202 265 6515 fax: +1 202 785 7689 e-mail: [email protected]
Dr Robert Hall Senior Research Fellow (WPRO TAG Chair) Monash University Department of Epidemiology and Preventive Medicine 85 Commercial Road Melbourne 3008 Victoria Austra l ia
tel: +61 3 9903 0555 fax: e-mail: [email protected]
Professor Lalitha Mendis President Sri Lanka Medical Council Emeritus Professor University of Colombo / Chairperson SEARO TAG on Immunisation University of Colombo 532/3G, Sirikotha Lane Colombo 3 Sri Lanka
tel: +94 11 2576907 fax: +94 11 269 8802 e-mail: [email protected]
Dr Ali Jaffer Mohamed Advisor Health Affairs & Supervising DGHA (EMRO TAG Chair) Ministry of Health, Sultanate of Oman Ministry of Health P. O. Box 393 Muscat Oman
tel: +968 24 600808 fax: +968 24 691162 e-mail: [email protected]
Version: 29.07.2009 5
Professor Peter Martins Ndumbe (Unable to attend) Dean, Faculty of Health Sciences, (AFRO TFI Chair (also Chair of IVAC) University of BUEA Molyko, PO Box 63 South West Province Buea Cameroon
tel: +237 3332 2134 / +237 3332 2813 fax: +237 3332 2813 e-mail: [email protected]; [email protected]
Dr Pierre Van Damme (Unable to attend) Professor, Vaccine & Infectious Diseases Institute (EURO ETAGE Chair) WHO Collaborating Center for Control and Prevention of Viral Hepatitis University of Antwerp Centre for the Evaluation of Vaccination Universiteitsplein 1 Antwerp 2610 Belgium
tel: +32 3 820 25 38 fax: +32 3 820 26 40 e-mail: [email protected]
Invited Experts
Dr Gary Grohmann FASM Director, Immunobiology & Manager of Prescription Medicines Office of Laboratories & Scientific Services Therapeutic Goods Administration P.O. Box 100 Woden ACT 2606 Austra l ia
tel: 612 6 232 8490 fax: 612 6 232 8564 e-mail: [email protected]
Dr Frederick Hayden (Linked by telephone) Influenza Research Coordinator International activities-Science Funding The Wellcome Trust 215 Euston Road London NW1 2BE United Kingdom of Great Br i ta in & Northern I re land
tel: +44 20 7611 8256 fax: +44 207 611 7288 e-mail: [email protected]
Dr Arnold Monto Director, The University of Michigan Bioterrorism Preparedness Initiative The University of Michigan School of Public Health 109 Observatory St. Ann Arbor 48109-2029 MI United States of America
tel: +1 734 764 5453 fax: +1 734 764 3192 e-mail: [email protected]
Observers
Ms Janis Bernat Scientific Assistant International Federation of Pharmaceutical Manufacturers and Associations 15, chemin Louis-Dunant P.O. Box 195 1211 Geneva 20 Switzer land
tel: +41 22 338 3225 fax: e-mail: [email protected]
Mr Olivier Brun Global Product Manager Crucell Berna Biotech Ltd. Rehhagstrasse 79 Bern 3018 Switzer land
tel: +41319806559 fax: e-mail: [email protected]
Version: 29.07.2009 6
Dr Sonia Villaseñor Bustamante Gerente de Exportaciones y Ventas Sector Privado International Business Manager Birmerx Amores 1240 Col del Valle del Benito Juarez 03100 Mexico
tel: (52-55) 5422-2873 fax: (52-55) 5422-2881 e-mail: [email protected]
Dr Iza Ciglenecki Medical advisor - response to epidemics and epidemiological support Médecins Sans Frontières Switzerland 78, Rue de Lausanne CP 116 1211 Geneva Switzerland
T tel. +41 22 849 8930 e-mail: [email protected]
Mr Nathan Wilcox telephone linked to listen Oliver Wyman 10 South Wacker Drive, 13th Floor Chicago IL 60606 United States of America
tel: +1 312 902 7915 fax: +1 312 902 7989 e-mail: [email protected]
Dr Alfred Da Silva Executive Director Agence de Médecine préventive s/c Institut Pasteur 25-28 rue du Dr Roux 75724 Paris Cedex 15 France
tel: 33 1 53 86 89 20 fax: 33 1 53 86 89 39 e-mail: [email protected]
Dr Stephen Gardner Director Market Access Influenza GlaxoSmithKline Parc de la Noire Epine Avenue Fleming 20 Wavre 1300 Belgium
tel: +32 2 656 92 67 fax: +32 2 656 81 27 e-mail: [email protected]
Dr Bruce Gellin Director Departement of health and Human Services 200 Independence Avenue SW Washington, DR 20201 United States of America
tel: 202- 690 55 66 fax:: 202-690 46 31 e-mail: bruce-gellin@hhs-gov
Dr Jesse L. Goodman Director Center for Biologics Evaluation and Research US Food and Drug Administration (FDA) 1401 Rockville Pike, Suite 200N Rockville MD 20852-1448 United States of America
tel: + 1 301 827 0372 fax: + 1 301 827 0440 e-mail: [email protected]; [email protected]
Mr Toru Gotanda Deputy President Kitasato Institute Biological Research Center 6-111 Arai Kitamotoshi Saitamaken 364-0026 Japan
tel: +81-48 593 3957 fax: +81 48 593 3851 e-mail: [email protected]
Version: 29.07.2009 7
Ms Stephanie Hardy Senior Policy Advisor - Vaccines Biologics and Genetic Therapies Directorate Health Canada Tunney's Pasture Ottawa K1A 0L2 Ontario Canada
tel: 1.613.957.8228 fax: e-mail: [email protected]
Dr Norbert Hehme Chairman, IVS International Task Force, Vice President Flu Manufacturing Strategy GSK Biologicals Zirkusstrasse 40, Dresden 01069 Germany
tel: +49 351 546 15104 fax: +49 351 456 15321 e-mail: [email protected]
Dr Jennifer Herz Medimmune 7 rue Sully Lyon 69006 France
tel: +33 6 16 80 47 26 fax: e-mail: [email protected]
Ms Sissel Hodne Steen Minister Counsellor Permanent Mission of Norway to the United Nations Office & other International Organizations at Geneva 31-35 Avenue de Budé Geneva 1202 Switzer land
tel: +41229180423 fax: +41229180410 e-mail: [email protected]
Dr Suresh S. Jadhav Executive Director Quality Assurance & Regulatory Affairs Serum Institute of India Limited 212/2 Hadapsar Pune 411 028 Ind ia
tel: +91 202 699 3900/26602379 fax: +91 202 699 3945/3921 e-mail: [email protected]
Dr Ryoko Krause Director Biologicals and Vaccines International Federation of Pharmaceutical Manufacturers and Associations 15, chemin Louis-Dunant P.O. Box 195 1211 Geneva 20 Switzer land
tel: +41 22 338 3212 fax: +41 22 338 3299 e-mail: [email protected]
Dr Cornelia Kutzer Senior Marketing Manager Global BioSecurity Baxter BioScience Baxter Hyland Immuno, Ufer Str. 15 Orth/Donau 2304 Austr ia
tel: +43 1 20100 1349 fax: +43 1 20100 5073 e-mail: [email protected]
Consellor Thor Erik Lindgren Permanent Mission of Norway to the United Nations Office & other International Organizations at Geneva 31-35 Avenue de Budé Geneva 1202 Switzer land
tel: +41229180423 fax: +41229180410 e-mail: [email protected]
Version: 29.07.2009 8
Professor Pierluigi Lopalco European Centre for Disease Prevention and Control Stockholm 171 83 Sweden
tel: +46 8 586 01 212 fax: +46 8 5860 1001 e-mail: [email protected]
Dr Dorothea Matysiak-Klose Robert Koch Institut DGZ - Ring 1 13068 Berlin Germany
tel: +49 30 4547 3414 fax: +49 30 4547 3533 e-mail: [email protected]
Dr Nobuhiko Okabe Director Division of Surveillance and Information National Institute of Infectious Diseases Infectious Disease Surveillance Centre 1-23-1 Toyama Shinjuku Tokyo 162 8640 Japan
tel: +81 3 5285 1111 fax: +81 3 5285 1129 e-mail: [email protected]
Dr Bram Palache Global Scientific and Public Affairs Director Influenza Vaccines Solvay Biologicals PO Box 900 1380 DA Weesp Nether lands
tel: +31 294 477542 fax: +31 294 417772 e-mail: [email protected]
Professor Christian Perronne Infectious Diseases Unit Hôpital Universitaire Raymond Poincaré Garches 92380 France
tel: +33 1 47 10 77 58 fax: +33 1 47 10 77 67 e-mail: [email protected]
Mr Jon Pearman GAVI Manager Accelerated Vaccine Introduction (AVI) GAVI Alliance Secretariat Geneva 10 Switzerland
tel: +41 22 909 65 30 fax: +41 22 909 65 50 mobile: +41 79 240 48 63 e-mail :[email protected]
Dr Samuel Ponce de León General Director Laboratorios de Biologicos y Reactivos de Mexico, S.A. de C.V Amores 1240 Colonia del Valle 06000 Mexico DF Mexico
tel: (52) 54-22-28-40 y (52) 54-22- fax: (52) 54-22-28-80 y (52) 54-22- e-mail: [email protected]
Dr Sai D.Prasad Project Manager – Rotavirus Vaccine Project Vice President Genome Valley Shameerpet, Hyderabad 500 078. A.P. India
tel: +91 40 2348 0567 fax: +91 40 2348 0560 e-mail: [email protected]
Version: 29.07.2009 9
Dr Manjari Quintanar Subdirector of the Coordination of the National Immunization Council Centro Nacional para la Salud de la Infancia y la Adolescencia Francisco de P. Miranda No. 177 1er. piso Col. Merced Gómez Deleg. Álvaro Obregón Mexico D.F. Mexico
tel: fax: e-mail: [email protected]
Mr Adam Sabow, Partner telephone linked to listen Oliver Wyman 10 South Wacker Drive, 13th Floor Chicago IL 60606 United States
tel: +1 312 902 7915 fax: +1 312 902 7989 e-mail: [email protected]
Professor Claire-Anne Siegrist Director of Pediatric Department Center for Vaccinology and Neonatal Immunology CMU 1 rue Michel-Servet, 1211 Geneva 4 Switzerland
tel: +22 379 57 78 fax: +22 379 58 01 e-mail: [email protected]
Dr Susan Tamblyn Public Health Consultant Public Health Agency in Canada Public Health Agency of Canada Tunney's Pasture PL 0602D Ottawa, Ontario K1A OK9 Canada
tel: 6138526036 fax: e-mail: [email protected]
Dr Russell Thirsk Novartis Vaccines and Diagnostics Inc. 350 Massachusetts Avenue MA 02139 Cambridge United Kingdom of Great Br i ta in & Northern I re land
tel: +1 617 871 7998 fax: e-mail: [email protected]
Mr Mayuko Toyota First Secretary Permanent Mission of Japan in Geneva 3,chemin des Fins 1218 Grand-Saconnex Geneva Suisse
tel: +41-22-717-3107 fax: +41-22-717-3774 e-mail: [email protected]
Dr Ronald Waldman U.S. Agency for International Development (USAID) Ronald Reagan Building 1300 Pennsylvania Avenue N.W. Washington, D.C. 20523-3700 United States of America
tel: fax: e-mail: [email protected]
Professor Albrecht Werner European Commission SANCO C Health Threats Unit HTC 02/264 11, Rue E. Ruppert 2920 Luxembourg
tel: 00352 4301 35290 fax: e-mail: [email protected]
Version: 29.07.2009 10
Ms Kine Willbergh Senior Adviser Norwegian Institute of Public Health PO Box 4404, Nydalen Oslo 0403 Norway
tel: +4721076494 fax: +4721076301 e-mail: [email protected]
Observers by telephone link
Dr Atika Abelin Director, Public Affairs Director, Public Affairs (IFPMA IVS Policy member) Sanofi Pasteur 2, avenue Pont Pasteur 69367 Lyon France
tel: +33 4 37377952 fax: +33 437377202 e-mail: [email protected]
Dr Marguerite Baxter VP Government Affairs Novartis Vaccines & Diagnostics 701 Pennsylvania Ave NW, Suite 725 Washington, DC 20004 United States of America
tel: +1 202 626-0100 fax: e-mail: [email protected]
Mrs Francesca Boldrini Executive Director, Global Public Affairs EU and International Organizations Novartis Vaccines & Diagnostics WSJ 210.2.30 4002 Basel Switzer land
tel: +41 61 32 43 265 fax: +41 61 324 20 16 e-mail: [email protected]
Mr John Budd Chief of Communication CEE CIS Region UNICEF (Geneva) 57 avenue de la Paix (Palais des Nations) 1211 Genève 10 Switzer land
tel: +41229095429 fax: e-mail: [email protected]
Dr Kathleen L. Coelingh Senior Director Medical & Scientific Affairs MedImmune Inc. 801 Pine Street, Apartment 25A, Seattle, 98101 WA United States of America
tel: +1 206 695 2823 fax: +1 650 603 3396 e-mail: [email protected]
Dr Toon Digneffe Director Governmental Affairs Baxter World Trade sa Bd de la Plaine Brussels 1050 Belgium
tel: +32 2 650 1672 fax: e-mail: [email protected]
Dr Anne Golaz Senior Health Advisor - Emergencies UNICEF 5-7 Avenue de la Paix 1211 Geneva 10 Switzer land
tel: +977 1 4419 471 fax: +977 1 4419 471 e-mail: [email protected]
Version: 29.07.2009 11
Dr Emmanuel Hanon Vice-President, Head of Influenza Vaccine Franchise GlaxoSmithKline Biologicals rue de l'institut 89 Rixensart Belgium
tel: +32 10 85 3319 fax: e-mail: [email protected]
Dr Luc Hessel Executive Director Sanofi Pasteur MSD 8 Rue Jonas Salk 69367 Lyon Cedex 07 France
tel: +33 437 28 40 70 fax: +33 437 28 44 11 e-mail: [email protected]
Dr Douglas Holtzman Senior Program Officer, Infectuous Diseases Global Health Program The Bill and Melinda Gates Foundation P.O. Box 23350 Seattle 98102 WA United States of America
tel: (206)709-3601 fax: (206)709-3170 e-mail: [email protected]
Dr Tomia Ikeda Deputy General Manager Vaccine R&D Department Denka Seiken Co. Ltd. 1-2-2 Minami-Honcho Gosen -shi, Niigata 959-1695 Japan
tel: +81 250 43 4111 fax: +81 250 43 4252 e-mail: [email protected]
Dr Yoichiro Kino General Manager Second Research Department The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN) 1-6-1 Okubo Kumamoto, 860-8588 Japan
tel: 81 968 37 4090 fax: +81 968 37 4350 e-mail: [email protected]
Dr Igor Krasilnikov Chief, Department of Research Microgen State Company Kozhevnichesky proesd, 4/3 115114 Moscow Russian Federat ion
tel: +007 495-790-77-73 fax: +007 495- 790-77-73 e-mail: [email protected] or [email protected]
Ms Christine Ding-Ping Liu Director Division of Acute Infectious Diseases & Immunization Centers for Disease Control Department of Health No. 6, Linshen South Road, 100 Taiwan (Chinese Taipei)
tel: +886-2-23959836 fax: +886-2-23945308 e-mail: [email protected]
Dr Osman Mansoor Public Health Physician Senior Adviser EPI (New Vaccines) UNICEF 3 United Nations Plaza New York 10017 NY United States of America
tel: 1 212 326 74 10 fax: 1 212 824 64 60 e-mail: [email protected]
Version: 29.07.2009 12
Dr Kathy Neuzil Senior Clinical Adviser Program for Appropriate Technology in Health 1455 NW Leary Way Seattle 98107 5136 WA United States of America
tel: +1 206 285 3500 fax: 1 206 285 6619 e-mail: [email protected]
Mrs Beatrice Progida Emergency preparedness specialist Pandemic focal point UNICEF 57 avenue de la Paix (Palais des Nations) 1211 Genève 10 Switzer land
tel: +41229095641 fax: e-mail: [email protected]
Dr Regina Rabinovich Director Infectious Diseases, Global Health Program The Bill and Melinda Gates Foundation P.O. Box 23350 Seattle, WA 98107-5136 United States of America
tel: +1 206 709 3490/3579 fax: +1 206 709 3170 e-mail: [email protected]
Dr David Ryan Technical Director Vaccines, CSL Pharmaceuticals Product Development 45 Poplar Road Parkville Victoria 3052 Austra l ia
tel: +61 3 9389 1911 fax: + 61 3 9389 1434 e-mail: [email protected]
Professor Barry D. Schoub Executive Director National Institute for Communicable Diseases Private Bag X4 Sandringham 2131 South Afr ica
tel: +27 11 38 66 390 fax: +27 11 38 66 455 e-mail: [email protected]
Dr R.K. Suri Senior Vice President New Initiative Panacea Biotech Ltd. B-1 Extension A-27 Mohan Co-op. Indl. Estate, Mathura Rd New Delhi Ind ia
tel: +91 11 41 67 90000 Extn. 2064 fax: +91 11 4167 9027 e-mail: [email protected]
Dr Masato Tashiro Director Department of Virology III (Viral Diseases & Vaccine Control) National Institute of Infectious Diseases WHO Collaborating Centre for Reference & Research of Influenza Gakuen 4-7-1 Musashi-Murayama Tokyo 208-0011 Japan
tel: 81 42 565 2498 fax: 81 42 565 2498 e-mail: [email protected]
Mr Jaap Venema Global Project Director Pandemic Solvay Biologicals PO Box 900 1380 DA Weesp Nether lands
tel: +31 294 479537 fax: +31 294 417772 e-mail: [email protected]
Version: 29.07.2009 13
Dr Richard Webby Department of Infectious Diseases 262 Danny Thomas Place Memphis TN 38105 United States of America
tel: +1 901 595 3014 fax: +1 901 523 2622 e-mail: [email protected]
Dr Ferenc Zimonyi Chief Executive Officer Ömninvest Vaccines Omnivest Vaccines Fö utca 7 Pilisborosjenö 2097 Hungary
tel: fax: +36 26 536 051 e-mail: [email protected]
Dr Yong Zou Medicine Manager Sinovac Biotech Ltd No 39 Shangdi Xi Road Haidian District Beijing 100085 People 's Republ ic of China
tel: +86 10 82799340 fax: e-mail: [email protected]
Version: 29.07.2009 14
Regional Offices
Dr Déo Nshimirimana Regional Adviser for VPD Regional Office for Africa (AFRO) Vaccine Preventable Diseases Division of Prevention and Control of Communicable Diseases Boîte Postale 6 Brazzaville Congo
tel: Ext.39203 fax: +47 241 39 501/3 e-mail: [email protected]
Dr Cuauhtémoc Ruiz Matus Regional Adviser/Unit Chief of Immunization Regional Office for the Americas (AMRO/PAHO) Immunization Unit, Room 511 252, 23rd Street Washington D.C. 20037 2895 United States of America
tel: 5200 3945 fax: e-mail: [email protected]
Dr Jaouad Mahjour (Unable to attend) Director, Communicable Diseases Control Regional Office for Eastern Mediterranean (EMRO) Abdul Razzak Al-Sanhouri Street P.O. Box 760 8, Nasr City Cairo 11371 Egypt
tel: +20 222 765 250 fax: +20 222 765 414 e-mail: [email protected]
Dr Rebecca Martin Targeted Diseases and Immunization Team Leader Communicable Diseases Unit (CDS) Regional Office for Europe (EURO) 8, Scherfigsvej Copenhagen 2100 Denmark
tel: +45 3917 1216 fax: +45 3917 1863 e-mail: [email protected]
Headquarters Secretariat
Dr.Asamoa-Baah Deputy Director-General DGD/DGO/ODG
tel: + 41 22 791 44 19 e-mail: [email protected]
Dr. Bruce Aylward Director Polio Eradication Initiative (POL)
tel: + 41 22 791 44 19 e-mail: [email protected]
Dr Sylvie Briand Global Influenza Programme (GIP) Epidemic and Pandemic Alert and Response (EPR) Communicable Diseases (CDS)
tel: + 41 22 791 2372 e-mail: [email protected]
Mr Peter Carrasco Expanded Programme on Immunization (EPI) Immunization, Vaccines and Biologicals (IVB)
tel: + 41 22 791 1512 e-mail: [email protected]
Dr Margaret Chan Director-General World Health Organization
Tel. +41 22 791 5858 e-mail: [email protected]
Dr Sudeep Chand Public Health Advisor (IVB)
tel: +44 75000 87002 e-mail: [email protected]
Dr Thomas Cherian Coordinator Expanded Programme on Immunization (EPI) Immunization, Vaccines and Biologicals (IVB)
tel: + 41 22 791 4460 e-mail: [email protected]
Version: 29.07.2009 15
Mr Alejandro Costa Epidemic Readiness and Interventions (ERI) Epidemic and Pandemic Alert and Response (EPR)
tel: + 41 22 791 4965 e-mail: [email protected]
Dr Philippe Duclos Senior Health Adviser/SAGE Executive Secretary Immunization Policy (ICP) Immunization, Vaccines and Biologicals (IVB)
tel: + 41 22 791 4527 e-mail: [email protected]
Dr Martin Friede Product Research and Development (RPD) Initiative for Vaccine Research (IVR) Immunization, Vaccines and Biologicals (IVB)
tel: 41 22 791 4398 e-mail: [email protected]
Dr Florence Fuchs Laboratory Quality Systems Lyon
tel: e-mail: [email protected]
Dr Keiji Fukuda Global Influenza Programme (GIP) Epidemic and Pandemic Alert and Response (EPR) Communicable Diseases (CDS)
tel: + 41 22 791 3871 e-mail: [email protected]
Dr Prakash Ghimire Epidemic and Pandemic Alert and Response (EPR) Global Influenza Programme (GIP)
tel. +41 22 791 2463 e-mail: [email protected]
Dr Marie-Paule Kieny Director Initiative for Vaccine Research (IVR) Immunization, Vaccines and Biologicals (IVB)
tel: + 41 22 791 3591 e-mail: [email protected]
Dr Jean-Marie Okwo-Bele Director Immunization, Vaccines and Biologicals (IVB)
tel: + 41 22 791 2779 e-mail: [email protected]
Dr Laszlo Palkonyay Product Research and Development (RPD) Initiative for Vaccine Research (IVR) Immunization, Vaccines and Biologicals (IVB)
tel: + 41 22 791 3488 e-mail: [email protected]
Dr Dina Pfeifer Quality, Safety and Standards (QSS) Immunization, Vaccines and Biologicals (IVB)
tel: + 41 22 791 2978 e-mail: [email protected]
Dr Cathy Roth Epidemic and Pandemic Alert and Response (EPR) Biorisk Reduction for Dangerous Pathogens (BDP)
tel: + 41 22 791 3896 e-mail: [email protected]
Dr Niteeen Wairagkar Epidemic and Pandemic Alert and Response (EPR) Global Influenza Programme (GIP)
tel: + 41 22 791 3786 e-mail: [email protected]
Dr David Wood Coordinator Quality, Safety and Standards (QSS) Immunization, Vaccines and Biologicals (IVB)
tel: + 41 22 791 4050 e-mail: [email protected]
Dr Wenqing Zhang Epidemic and Pandemic Alert and Response (EPR) Global Influenza Programme (GIP)
tel: + 41 22 791 4282 e-mail: [email protected]
Dr Patrick Zuber Expanded Programme on Immunization (EPI) Immunization, Vaccines and Biologicals (IVB)
tel: + 41 22 791 1521 e-mail: [email protected]
